Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands

Severe infection of infants with respiratory syncytial virus (RSV) is a leading cause of morbidity in the developed world and mortality in the developing world. Prophylaxis using palivizumab in infants at risk for severe RSV disease reduces the rate of hospitalisation in this population of children....

Descripción completa

Detalles Bibliográficos
Autores principales: Whelan, Barbara, Musters, Elles, Murray, Amanda, Moore, Eilish, Lievaart, Lenie, Visser, Sjoerd, Toxopeus, Esther, van Veen, Annemarie, Notario, Gerard, Campbell, Fiona J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Therapy in Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754330/
https://www.ncbi.nlm.nih.gov/pubmed/26924927
http://dx.doi.org/10.1007/s40267-015-0275-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754330/
https://www.ncbi.nlm.nih.gov/pubmed/26924927
http://dx.doi.org/10.1007/s40267-015-0275-0

Ejemplares similares